ABSTRACT-Fifty cases of breast carcinoma were investigated for Nm23, LPA1, Ki67 and p53 antigen expression, using immunohistochemical techniques. Correlation between markers was studied. Nm23 showed an inverse correlation with LPA1 and Ki67, and positive with p53. Nm23/LPA1presented significant (p<0.001) negative correlation with p53, but not difference were observed with Ki67. It can be concluded that: 1) Nm23 and LPA1 tend to be inversely correlated; 2) Nm23 correlates positively with p53, regardless of tumour type and patient's hormonal status; 3) Nm23 shows a reverse trend in comparison with Ki67. However, more studies are needed to determinate if hormone receptors play some role in the inverse relationship between Nm23-LPA1 and to know the tumour type implication in these relationships.
INTRODUCTION
Breast cancer is a heterogeneous disease, comprising multiple entities associated with distinctive histological and biological features, clinical presentations and behaviours and responses to therapy [1;2] . Tumor cell invasion is a complex process and the mechanisms controlling the transition from ductal carcinomas in situ to invasive ductal carcinoma still remain unclear, despite research in recent years [3] .
Various biological makers known to be indicators of prognosis in breast cancer include growth factor receptors, estrogen receptors, p53, and proliferation indices like Ki67. Majority of breast cancer patients succumb to metastatic disease.
The molecular basis of the metastatic disease is not known, but activation or inactivation of multiple genes is involved in the various steps of tumour progression [4;5] .
The first Nm23 gene was discovered by Steeg et al. in 1988 [6] on the basis of its reduced expression in the highly metastatic murine myeloma cell lines, as compared to their nonmetastatic counterparts [6;7] . * Correspondence to: R. Arriazu, Department of Basic Medical Sciences, School of Medicine, San Pablo-CEU University e-mail: arriazun@ceu.es Similar trends were identified in other model systems. Low Nm23-H1 expression in human tumours often correlated with poor patient survival although it is not considered to be an independent prognostic factor [8] .
Another growing target of interest is LPA1 (also known as EDG2), one of the receptors for LPA (lysophosphatidic acid). LPA1 is involved in a variety of physiological functions such as cellular proliferation, differentiation, prevention of apoptosis, migration, invasion, regulation of actin cytoskeleton, modulation of cell shape, and survival [9;10] .
The aim of this study was to investigate: 1) the immunohistochemical expression of Nm23 and LPA1 in breast carcinomas; 2) correlation between expressions of Nm23 with LPA1 and with other traditional markers in breast cancer diagnosis; and 3) correlation between expressions of Nm23/LPA1 and with other clinicopathology variables.
MATERIALS AND METHODS
Formalin fixed paraffin-embedded blocks of breast lesions were retrieved from the archives of the Service of Pathology, Hospital Madrid Montepríncipe, Madrid, Spain, where classified the carcinomas in histological type and grade. There were 50 samples in total distributed into two groups as: invasive ductal carcinoma (grade 1 (n = 4), 2 (n = 9) or 3 (n = 21)), and invasive lobular carcinoma (mixed (tubulolobular)
Table1. Primary antibodies used for immunohistochemistry.
carcinoma grade 2 (n = 1), lobular carcinoma (n = 12), and pleomorphic lobular carcinoma grade 3 (n = 3)).
Blocks of breast lesions were serially sectioned at five µm-thicknesses and stained with hematoxylineosine or used for immunohistochemical techniques.
Immunohistochemical Methods
Slices were deparaffinized and rehydrated tissue sections were treated for 30 min with hydrogen peroxide 0.3% in phosphate-buffered saline (PBS) pH 7.4, to block endogenous peroxidase, antigen unmasking was performed with pepsin (15 min, Sigma R2283). To minimize nonspecific binding, sections were incubated with serum blocking solution (Histostain® Bulk Kit, Invitrogen Corporation, Carlsbad, California) and subsequently incubated overnight with primary antibodies in a moist chamber at 4ºC. Information on primary antibodies is provided in Table 1 .
The second day, immunohistochemistry was performed with standard procedures using Histostain® Bulk Kit (Invitrogen Corporation, Carlsbad, California). After immunoreactions, sections were counter-stained with Harris hematoxylin, dehydrated in ethanol, and mounted in a synthetic resin (Depex, Serva, Heidelberg, Germany).
The specificity of the immunohistochemical procedures was checked by incubation of sections with nonimmune serum instead of the primary antibody.
Clinical Methods
ER, PR, Ki67, and p53 were evaluated by the pathologist visually, providing a semi-quantitative estimate of the percentage of positive cells.
Image Analysis
To establish the immunostaining percentage area of Nm23 and LPA1, ten digital images were acquired for each slide. To determinate the threshold values that discriminated the immunostaining from the counterstain and background, the red-green-blue (RGB) color mode values were converted to HSI values using MetaMorph software (Leica MMAF 1.4). The HSI system is thought to offer a much closer approximation to the behavior of human color vision than do untransformed RGB values [11] .
We next defined the ''negative-chromaticity subdomain'' following the methodology described by Maximova et al. (2006) [12] . Finally, we defined a positive-chromaticity subdomain-a set of HSI threshold value ranges selected such that no pixel with the negative-control hue would confound the identification of positively stained areas.
Statistical Analisis
Statistical analysis was conducted using Pearson's correlation coefficient test. Differences were considered significant when p < 0.001. Missing data were removed in pairs. The software used was Excel 2010 version 14.0.6 (SP1) 
RESULTS

Qualitative results
Nm23 expression was strongly detected in epithelial cytoplasm of normal acini. Epithelial cells that had lost their normal histological structure also showed Nm23 staining (figs. 1a,b). LPA1 expression was identified at epithelial cytoplasm as occurred with Nm23, but in this case, immunostaining was weaker (figs. 1c-d).
Immunoreactivity to p53 was identified in cytoplasm and nuclear epithelial cells from all samples studied (figs. 2a,b). Nuclear p53 immunostaining was also remarkable in the acini with histological changes ( fig. 2b ). Ki67 immunoreactivity was observed in the nuclei of epithelial cells of the acini. There were two types of Ki67 staining: homogeneous nuclear staining, and granular staining. The first one was more intensive than the second one ( fig. 3 ).
ER and PR immunoexpression was found in the nuclei of epithelial cells from all samples studied (figs. 4a,b). 
Quantitative results
All cases were classified en two huge groups attending hormonal receptors immunoexpression into Invasive Ductal Carcinoma (IDC), and Invasive Lobular Carcinoma (ILC).
Invasive Ductal Carcinoma (IDC):
Groups of patients without positive hormonal receptors: In this group (n=7), 6 cases were Nm23-positive. The Nm23 index ranged between 2 and 97%, averaging 28.51%. LPA1 expression was found in 5 cases. LPA1 index ranged between 0 and 43%, averaging 8.15%. All cases were immunopositive to Ki67. The Ki67 averaging was 25.57% and Ki67 index ranged between 18 and 35%. p53 immunoexpression was observed in 2 cases, but index range were wide, between 0 and 95%, averaging 2.57% (Tables 2,3) .
Patient with ER positive:
Only one case was ER+ and PR-. All immunohistochemistry done were positive (see Tables 2,3 ). This group was not taken part in the study of correlations.
Patient with PR positive: Only one case was PR+ and ER-. As in the previous case, all markers were positive (Tables 2,3 ). This group neither formed part of the analysis of correlations.
Groups of patients with positive hormonal receptors:
This group was the biggest (n=25), 23 cases were Nm23-positive. The Nm23 index ranged between 0 and 95%, averaging 42.08%. LPA1 expression was found in 17 cases. LPA1 index ranged between 0 and 63%, averaging 9.06%. All cases were immunopositive to Ki67. The Ki67 averaging was 15.64% and Ki67 index ranged between 10 and 25%. p53 immunoexpression was observed in 13 cases, index range between 0 and 95%, averaging 18% (Tables 2,3) .
Invasive Lobular Carcinoma (ILC):
Groups of patients without positive hormonal receptors: No patients were included in this group (Tables 2,3) .
Patient with ER positive:
Only one case was ER+ and PR-. All immunohistochemistry done were positive (Tables 2,3 ). This group was not taken part in the study of correlations.
Patient with PR positive:
No patients were included in this group (see Tables 2,3) .
Groups of patients with positive hormonal receptors:
In this group (n=15), 13 cases Nm23 positive, 13 cases LPA1 positive, 15 cases Ki67 positive, and 3 cases p53 positive were observed. The Nm23 index ranged between 0 and 94%, averaging 33.45%. LPA1 index ranged between 0 and 80%, averaging 13.97%. The Ki67 averaging was 11.2% and Ki67 index ranged between 7 and 13%. p53 index range between 0 and 2%, averaging 04% (Tables 2,3 ).
Table2. Relationship between marker positivity and carcinomas classified according to hormonal receptors expression. 
Ratio of positives cases
Nm23 protein expression and its correlation with the clinicopathology variables
Correlation between Nm23 and LPA1 and traditional prognostic markers in breast carcinoma was done, as well as Nm23/LPA1 and clinicopathology variables. Groups with 1 or 0 patients were eliminated. Only significant differences were found in Nm23/LPA1 and p53 in IDC ER-PR-. Pearson correlation coefficient is showed in Tables 4 and 5 
DISCUSSION
Several authors have been reported that ILC has characteristics and behaviors that are different from IDC [13;14] , but it is unclear which of the two types showed better prognosis [15;16] . Therefore, in this study breast carcinoma samples had been separated into these two groups. After that, samples were classified attending the Antimetastatic genes, such as Nm23, play an important role in the porgression of breast cancer [20] . Several researchers have observed the probable inverse association of Nm23 expression with disease prognosis and/or metastasis [21] . Metastatic process involves activation and down regulation of multiple genes at each step of metastatic cascade [4] . Nm23 expression has been widely studied in various cancers and with their relation to staging and prognosis. Bal A et al. (2008) [4] results implicate that lack of Nm23 expression in early lesions may be predictive of progression to invasive carcinoma and thus could be helpful in predicting the aggressiveness of the disease.
In mestastatic cascade are implicated a number of molecules such as LPA1. Horak et al. (2007) [22] demostrated by in vitro studies, an inverse correlation between Nm23 and LPA1 . They observed in vivo that LPA1 could play an importan role in the promotion of metastasis. In our work, Pearson correlation coefficients Nm23 versus LPA1 were negative in all groups analysed. Not significant differences were detected probably because sample size was not enough big. However, the relationship between Nm23 and LPA1 showed an inverse correlation, as described Horak et al. (2007) [22] .
p53 is the most frequently mutated gene in human cancer and is the founding member of the p53 family. In response to various cellular stresses, p53 regulates a variety of cellular functions including cell cycle progression, apoptosis, senescence, cell motility, DNA repair, genetic instability and cell metabolism by transcriptionally activating a variety of cellular genes [23] [24] [25] . Jung et al. (2007) [25] showed that Nm23-H1 and its binding partner STRAP (serinethreonine kinase receptor-associated protein) interacted with p53 and potentiated p53 activity. Both NM23-H1 and STRAP directly interacted with the central DNA binding domain within residues 113-290. The use of Nm23-H1 and STRAP mutants revealed that Cys(145) of Nm23-H1 and Cys(152) or Cys(270) of STRAP were responsible for p53 binding. Furthermore, Cys(176) and Cys(135) of p53 were required to bind Nm23-H1 and STRAP, respectively.
There is no consensus on expression of p53 when studying different carcinomas. Some authors associated p53 with a poor disease prognosis [26] and others with a high survival and good response to the treatment [27] . Simone et al. (2001) [28] found a positive correlation between presences of p53 with that of Nm23 histological samples, but Midulla el at. (1999) [29] were not observed any correlation within these two markers. This study is accorded with Jung et al. (2007) [25] and Simone et al. (2001) [28] . Note that the ratio Nm23/LPA1 was statistically significant for the group IDC ER-PR-. Maybe LPA1 plays an opposite role in p53 expression. In this regard, Hurst-Kennedy et al. (2009) [30] showed in an in vitro study with chondrocytes that LPA1 prevented apoptotic signalling by decreasing the abundance, nuclear localization, and transcriptional activity of the tumoursuppressor p53.
Ki67 is expressed in G1-, S-, G2 and mitosis phase. Nm23 has been correlation inversely with Ki67 in melanoma of the oral cavity and bladder tumour, showing a low expression of Ki67 in benign tissues and high expression of Nm23 in this tumour type [31] . Also, decrease of Nm23 expression, but not Ki-67, was significantly correlated with lymph node metastasis of breast invasive ductal carcinoma [32] . In all cases studied, there is an inverse correlation between Nm23 or Nm23/LPA1 and Ki67, although none of them was significant.
In summary, it can be concluded that: 1) Nm23 and LPA1 tend to be inversely correlated; 2) Nm23 correlates positively with p53, regardless of tumour type and patient's hormonal status; 3) Nm23 shows a reverse trend in comparison with Ki67. However, more studies are needed to determinate if hormone receptors play some role in the inverse relationship between Nm23-LPA1 and to know the tumour type implication in these relationships.
